Established since 1951, Biose Industrie provides a full range of services as a CDMO for microbiome therapeutics (LPBs) and Next Generation Probiotics.

Biose Industrie is the world leading CDMO for microbiome therapeutics and Next Generation Probiotics. Our facilities comprise a center of excellence of 52 000m2 based in Aurillac, …

2024年12月30日 · Biose’s year in review . Reflecting on 2024, I am incredibly proud of the achievements of our team at Biose Industrie: 600+ bacterial strains manufactured. 80+ drug …

2024年10月10日 · Microbiotica and Biose worked closely together, running 12 production runs over a 5-month period. The process required assessment of multiple variables including raw …

Established since 1951, Biose Industrie provides a full range of services as a CDMO for microbiome therapeutics (LPBs) and Next Generation Probiotics.

Established since 1951, Biose Industrie provides a full range of services as a CDMO for microbiome therapeutics (LPBs) and Next Generation Probiotics.

2023年2月17日 · L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a …

Established since 1951, Biose Industrie provides a full range of services as a CDMO for microbiome therapeutics (LPBs) and Next Generation Probiotics.

Established since 1951, Biose Industrie provides a full range of services as a CDMO for microbiome therapeutics (LPBs) and Next Generation Probiotics.

2020年10月16日 · Biose Industrie’s manufacturing practices (GMP) and facilities already pass muster with the European regulatory agencies, and the company is also making good …